Valsartan Recall Expands as FDA Investigation Continues
On August 8, 2018, FDA announced an expanded list of recalled Valsartan drugs due to their contamination with the known cancer-causing agent NDMA. While the original FDA announcement on July 13, 2018, only concerned the Valsartan-containing products from three pharmaceutical manufacturers, the most recent list published by the FDA reveals that the contamination was much more widespread. Indeed, the list now covers 55 drugs manufactured by 12 different companies distributing products in the United States.
The FDA’s investigation is ongoing into the levels of contamination, the reason behind the contamination, and the potential risks associated with past ingestion. What is known however is that NDMA definitively causes cancer in animals and is reasonably anticipated to be a human carcinogen.
If you or a loved one have taken Valsartan and have had liver, bladder, or kidney cancer or disease, contact one of the experienced dangerous drug attorneys at Burg Simpson today to discuss your legal rights. Call us at 1-800-713-9340 or fill out our contact form here for a FREE no-obligation consultation today.